Incyte Corporation
UEI: ZTM9U2G5VTK8
• CAGE: 1F8A9
Overview
Awardee Type
Parent
Company Description
Incyte is a global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines..
Name
Incyte Corporation
Website
Headquarters
Wilmington, DE
United States
United States
Most Recent Award
July 2, 2024
Calculating
Federal contract recipient
INCYTE CORPORATION
(UEI ZTM9U2G5VTK8, CAGE 1F8A9)
is headquartered in Wilmington DE.
Its primary registered NAICS is 325412 Pharmaceutical Preparation Manufacturing.
The corporation
was founded in April 1991 and
federally registered in
February 2001.
Federal Award Analysis
Incyte Corporation federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
INCYTE CORPORATION
UEI
ZTM9U2G5VTK8
CAGE Code
1F8A9
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
April 1, 1991
Initial Registration
Feb. 23, 2001
Last Registration
April 4, 2025
Registration Activation
April 4, 2025
Registration Expiration
April 2, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Manufacturer of Goods
Manufacturer of Goods
State of Incorporation
DE
Country of Incorporation
USA
Employees
>1500
Reported NAICS
Reported PSC
Accepts Credit Cards
No
People
Vendor contacts at Incyte Corporation
GSA Schedules and Price Lists
- Incyte Corporation
- PoP: 8/14/20 - 2/14/26
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Obligated: $465,132
- Incyte Corporation
- PoP: 6/30/13 - 8/15/20 (Ended)
- Obligated: $16,638